Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$651M |
| 2 |
Monster Beverage
MNST
|
$615M |
| 3 |
Intercontinental Exchange
ICE
|
$556M |
| 4 |
Johnson & Johnson
JNJ
|
$382M |
| 5 |
Applied Materials
AMAT
|
$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
$1.95B |
| 2 |
Texas Instruments
TXN
|
$771M |
| 3 |
Deere & Co
DE
|
$597M |
| 4 |
Meta Platforms (Facebook)
META
|
$543M |
| 5 |
Microsoft
MSFT
|
$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
276
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $102M | 0.05% |
1,070,621
+1,799
| +0.2% | +$172K |
|
277
Geron
GERN
$893M
| $102M | 0.05% |
22,565,846
+13,163,889
| +140% | +$59.6M |
|
278
Ligand Pharmaceuticals
LGND
$3.25B
| $101M | 0.05% |
1,009,094
+361
| +0% | +$36.1K |
|
279
Xenon Pharmaceuticals
XENE
$3.02B
| $101M | 0.05% |
2,552,392
+1,507,135
| +144% | +$59.3M |
|
280
Constellium
CSTM
$2.04B
| $100M | 0.05% |
6,152,955
+971
| +0% | +$15.8K |
|
281
Stride
LRN
$7.01B
| $99.9M | 0.05% |
1,170,434
+13,050
| +1% | +$1.11M |
|
282
NeoGenomics
NEO
$1.03B
| $97.4M | 0.05% |
6,603,180
-16,156
| -0.2% | -$238K |
|
283
Spotify
SPOT
$146B
| $97.3M | 0.05% |
264,233
+257,706
| +3,948% | +$94.9M |
|
284
AST SpaceMobile
ASTS
$11.4B
| $94.9M | 0.05% |
3,629,085
-3,825,815
| -51% | -$100M |
|
285
CACI
CACI
$10.4B
| $94.3M | 0.05% |
186,964
-449
| -0.2% | -$227K |
|
286
Donaldson
DCI
$9.44B
| $94M | 0.05% |
1,274,771
-113,729
| -8% | -$8.38M |
|
287
AvalonBay Communities
AVB
$27.8B
| $93.8M | 0.05% |
416,461
+43,206
| +12% | +$9.73M |
|
288
Cencora
COR
$56.7B
| $93.1M | 0.05% |
413,437
-502,541
| -55% | -$113M |
|
289
Advanced Drainage Systems
WMS
$11.5B
| $92.6M | 0.05% |
589,140
+953
| +0.2% | +$150K |
|
290
Neurocrine Biosciences
NBIX
$14.3B
| $91.3M | 0.05% |
792,196
-179,007
| -18% | -$20.6M |
|
291
Mirion Technologies
MIR
$5.28B
| $89.7M | 0.05% |
8,100,777
-584,490
| -7% | -$6.47M |
|
292
Applied Therapeutics
APLT
$68.2M
| $89.7M | 0.05% |
10,541,528
+2,893,323
| +38% | +$24.6M |
|
293
Clarivate
CLVT
$2.96B
| $89.2M | 0.05% |
12,565,739
-1,679,043
| -12% | -$11.9M |
|
294
Equity Lifestyle Properties
ELS
$12B
| $87.2M | 0.04% |
1,221,850
-10,210
| -0.8% | -$728K |
|
295
Cullen/Frost Bankers
CFR
$8.24B
| $86.9M | 0.04% |
777,082
-46,061
| -6% | -$5.15M |
|
296
Wynn Resorts
WYNN
$12.6B
| $86.6M | 0.04% |
902,880
-165,706
| -16% | -$15.9M |
|
297
Teva Pharmaceuticals
TEVA
$21.7B
| $86.4M | 0.04% |
4,791,937
+4,732,374
| +7,945% | +$85.3M |
|
298
Saia
SAIA
$8.34B
| $86M | 0.04% |
196,784
-517
| -0.3% | -$226K |
|
299
Aptiv
APTV
$17.5B
| $85.8M | 0.04% |
1,190,661
-175,579
| -13% | -$12.6M |
|
300
Paylocity
PCTY
$9.62B
| $85.4M | 0.04% |
517,931
+17,560
| +4% | +$2.9M |
|